ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2023
HIGH SALES GROWTH AND STRONG PROFITABILITY IN THE FIRST QUARTER
Revenues during the first quarter of 2023 amounted to SEK 393.7 (334.4) million, which corresponded to 18% (0%) growth compared to the corresponding period last year. EBITDA increased to SEK 44.4 (25.8) million and the EBITDA margin increased to 11.3% (7.7%), which showed that the company has managed to increase profitability through efficiency and economies of scale despite high inflation and great uncertainty around the world. During the quarter, there was also the start of sales in Turkey and the launch of new digital tools for the company's distributors in Scandinavia.
JANUARY-MARCH
• The total revenues amounted to SEK 393.7 (334.4) million, which corresponds to a growth of 18% (0%)
• The gross profit amounted to SEK 130.7 (99.3) million and the gross profit margin amounted to 33.2% (29.7%)
• EBITDA amounted to SEK 44.4 (25.8) million and the EBITDA margin to 11.3% (7.7%)
• Cash flow from current operations amounted to SEK 65.0 (-8.9) million
• Cash and cash equivalents on the balance sheet date amounted to SEK 216.4 (217.9) million
Link to the report:
https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/
For more information please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, email: dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, email: fredrik.nielsen@zinzino.com
Images for free publication:
marketing@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
This information is information that Zinzino AB (publ) is obliged to make public according to the EU's market abuse regulation. The information was provided by the above contact person for publication at 08.00 on 12 May 2023.
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.